Biotricity, Inc. (BTCY) Q3 2026 Earnings Name Transcript

Operator

Good afternoon, and welcome to Biotricity’s Third Quarter Fiscal 2026 Monetary Outcomes and Enterprise Replace Convention Name. Immediately’s convention is being recorded. As a reminder, that is Biotricity’s Third Quarter fiscal 2026 ended on December 31, 2025. So all figures introduced for this era will replicate that finish date. Earlier, Biotricity issued its earnings press launch for the interval, which highlighted monetary and operational outcomes. A replica of the press launch is offered on the Investor Relations part of the Biotricity’s web site, and the total financials have been filed with the SEC on Type 10-Q and posted on EDGAR at www.sec.gov.

Earlier than starting the corporate’s formal remarks, I would wish to remind listeners that immediately’s dialogue could include forward-looking statements that replicate administration’s present views with respect to future occasions. Any such statements are topic to dangers and uncertainties that would trigger precise outcomes to vary materially from these projected in these forward-looking statements. Biotricity doesn’t undertake to replace any forward-looking statements, besides as required. At this level, I am happy to show the decision over to Biotricity’s Founder and CEO, Dr. Waqaas Al-Siddiq. Please go forward, sir.

Waqaas Al-Siddiq
Founder, President, CEO & Chairman

I want to first thank everyone for becoming a member of us immediately. This quarter marks one other necessary step for Biotricity as we proceed executing our confirmed technique, evidenced by 3 consecutive quarters of optimistic internet working earnings and EBITDA. As we proceed scaling income and enhancing margins, we’re strengthening our management place in continual care markets, beginning with the #1 international explanation for loss of life, heart problems.

This quarter continues our historic development of increasing our